| Immunotherapy for lung cancer A Steven, SA Fisher, BW Robinson Respirology 21 (5), 821-833, 2016 | 333 | 2016 |
| Tumor progression despite efficient tumor antigen cross-presentation and effective “arming” of tumor antigen-specific CTL DJ Nelson, S Mukherjee, C Bundell, S Fisher, D Van Hagen, B Robinson The Journal of Immunology 166 (9), 5557-5566, 2001 | 85 | 2001 |
| Growth in the Presence of Salicylate Increases Fluoroquinolone Resistance in Staphylococcus aureus JE Gustafson, PV Candelaria, SA Fisher, JP Goodridge, TM Lichocik, ... Antimicrobial Agents and Chemotherapy 43 (4), 990-992, 1999 | 78 | 1999 |
| The “Trojan Horse” approach to tumor immunotherapy: targeting the tumor microenvironment D Nelson, S Fisher, B Robinson Journal of immunology research 2014 (1), 789069, 2014 | 63 | 2014 |
| Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action CM Tilsed, SA Fisher, AK Nowak, RA Lake, WJ Lesterhuis Frontiers in oncology 12, 960317, 2022 | 55 | 2022 |
| Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy N Principe, J Kidman, S Goh, CM Tilsed, SA Fisher, VS Fear, CA Forbes, ... Frontiers in Immunology 11, 584423, 2020 | 53 | 2020 |
| Combination immune checkpoint blockade as an effective therapy for mesothelioma VS Fear, C Tilsed, J Chee, CA Forbes, T Casey, JN Solin, SM Lansley, ... Oncoimmunology 7 (10), e1494111, 2018 | 45 | 2018 |
| Transient Treg depletion enhances therapeutic anti-cancer vaccination SA Fisher, WJ Aston, J Chee, A Khong, AL Cleaver, JN Solin, S Ma, ... Immunity, Inflammation and Disease, 1-13, 2016 | 44 | 2016 |
| Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen J Creaney, S Ma, SA Sneddon, MR Tourigny, IM Dick, JS Leon, A Khong, ... Oncoimmunology 4 (7), e1011492, 2015 | 32 | 2015 |
| The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40 A Khong, AL Cleaver, M Fahmi Alatas, BC Wylie, T Connor, SA Fisher, ... BMC cancer 14, 1-9, 2014 | 29 | 2014 |
| Chemotherapy Enhances Cross-Presentation of Nuclear Tumor Antigens CC Anyaegbu, RA Lake, K Heel, BW Robinson, SA Fisher PLoS ONE 9 (9), e107894, 2014 | 25 | 2014 |
| The search for an interesting partner to combine with PD-L1 blockade in mesothelioma: focus on Tim-3 and LAG-3 E Marcq, JRM Van Audenaerde, J De Waele, C Merlin, P Pauwels, ... Cancers 13 (2), 282, 2021 | 21 | 2021 |
| Tumour draining lymph node‑generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used VS Fear, CA Forbes, N S.A, F S.A, J Chee, J Waithman, S Ma, RA Lake, ... Cancer Immunology, Immunotherapy, 2021 | 19 | 2021 |
| Bibliometric analysis of gaps in research on asbestos-related diseases: declining emphasis on public health over 26 years RT Lin, MJ Soeberg, LC Chien, S Fisher, J Takala, R Lemen, T Driscoll, ... BMJ Open 8 (7), e022806, 2018 | 19 | 2018 |
| Lack of ignorance to tumor antigens: evaluation using nominal antigen transfection and T-cell receptor transgenic lymphocytes in Lyons-Parish analysis—implications for tumor … BWS Robinson, BM Scott, RA Lake, PA Stumbles, DJ Nelson, S Fisher, ... Clinical cancer research 7 (3), 811s-817s, 2001 | 18 | 2001 |
| Interferon-γ response by peripheral blood mononuclear cells to hepatitis C virus core antigen is reduced in patients with liver fibrosis MW Watson, A Jaksic, P Price, W Cheng, M McInerney, MA French, ... The Journal of infectious diseases 188 (10), 1533-1536, 2003 | 16 | 2003 |
| Neoadjuvant anti-tumor vaccination prior to surgery enhances survival SA Fisher, A Cleaver, DD Lakhiani, A Khong, T Connor, B Wylie, ... Journal of Translational Medicine 12, 1-9, 2014 | 12 | 2014 |
| Combining chemotherapy and checkpoint blockade in thoracic cancer: how to proceed? WJ Aston, SA Fisher, A Khong, C Mok, AK Nowak, RA Lake, ... Lung Cancer Management 3 (6), 443-457, 2014 | 8 | 2014 |
| CD4+ T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment responsive to chemotherapy CM Tilsed, N Principe, J Kidman, WL Chin, MLO Morales, RM Zemek, ... Cell Reports 41 (13), 2022 | 7 | 2022 |
| Comprehensive testing of chemotherapy and immune checkpoint blockade in preclinical cancer models identifies additive combinations N Principe, WJ Aston, DE Hope, CM Tilsed, SA Fisher, L Boon, IM Dick, ... Frontiers in immunology 13, 872295, 2022 | 5 | 2022 |
Bruce Robinsonuniversity of western austRALIA在 uwa.edu.au 的电子邮件经过验证
